Status Epilepticus Treatment
Introduction to Treatment
- The American College of Emergency Physicians recommends starting status epilepticus treatment with benzodiazepines as the first line, followed by second-line anticonvulsants such as valproate, phenytoin, or levetiracetam, and considering anesthetics like propofol or barbiturics in refractory cases 1
- Simultaneously with anticonvulsant treatment, it is essential to search for and correct treatable causes such as hypoglycemia, hyponatremia, hypoxia, drug toxicity, and CNS infections 1
Second-Line Treatment Options
- Valproate IV: 30 mg/kg at a speed of 5-6 mg/kg/min shows similar or superior efficacy to phenytoin (88% vs 84%) with a significant advantage of lower risk of hypotension (0% vs 12% with phenytoin) 2, 1
- Phenytoin/Fosphenytoin IV: 20 mg/kg at a maximum speed of 50 mg/min has demonstrated efficacy but with a higher risk of cardiovascular adverse effects, requiring continuous ECG and blood pressure monitoring 2, 1
- Levetiracetam IV: 30 mg/kg (2500 mg maximum) has efficacy similar to valproate (73% vs 68%) with a favorable safety profile and no significant cardiovascular effects 3, 4
Refractory Status Epilepticus Treatment
- Propofol: bolus of 2 mg/kg followed by infusion of 3-7 mg/kg/hour has the advantage of shorter mechanical ventilation time compared to barbiturics (4 vs 14 days) 3, 4
- Barbiturics (phenobarbital): 100-1000 mg IV should be considered in super-refractory cases 2
Phenytoin Administration Protocol in Pediatric Status Epilepticus
Monitoring Requirements and Important Considerations
- The American College of Emergency Physicians notes that hypotension occurs more frequently with phenytoin than with alternatives like valproate, emphasizing the need for continuous monitoring of electrocardiogram and blood pressure during administration 5, 6
- Phenytoin has only shown 56% success in terminating status epilepticus when used after benzodiazepines, highlighting the importance of careful patient selection and monitoring 7, 8